Trademark Overview
On Monday, April 15, 2024, a trademark application was filed for DACRA with the United States Patent and Trademark Office. The USPTO has given the DACRA trademark a serial number of 98500219. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 15, 2024. This trademark is owned by Key Bioscience AG. The DACRA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical drugs for the treatment of metabolic disorders, namely, obesity, comorbidities secondary to obesity, metabolic syndrome, and related metabolic diseases; Pharmaceutical drugs for the treatment of joint disorders and osteoarthritis